Clinical Trial Update: Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)

View source ↗

Summary

An update on a completed clinical trial evaluating circulating tumor cells as a blood-based biomarker in patients with small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Small Cell Lung Cancer | Status: COMPLETED